Vortioxetine (Lu AA21004) in the long-term open-label treatment of major depressive disorder

Current Medical Research and Opinion

Volumn 28, Issue 10, 2012, Pages 1717-1724

  Baldwin, David S ^a   Hansen, Thomas ^b   Florea, Ioana ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b H LUNDBECK A S   (Denmark)

Author keywords

Effectiveness; MADRS; Multimodal; Remission; Response; Tolerability; Vortioxetine

Indexed keywords

DULOXETINE; PLACEBO; VORTIOXETINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EXPOSURE; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; ERECTILE DYSFUNCTION; FEMALE; HAMILTON ANXIETY SCALE; HEADACHE; HUMAN; INFLUENZA; INSOMNIA; LABORATORY TEST; LIBIDO DISORDER; LONG TERM CARE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NAUSEA; OPEN STUDY; ORGASM DISORDER; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; RELAPSE; REMISSION; RHINOPHARYNGITIS; SEXUAL DYSFUNCTION; SIDE EFFECT; VITAL SIGN; WEIGHT GAIN; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; DEPRESSIVE DISORDER, MAJOR; ELECTROCARDIOGRAPHY; FEMALE; HEADACHE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NASOPHARYNGITIS; NAUSEA; PIPERAZINES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SULFIDES;

EID: 84867885144     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2012.725035     Document Type: Article

References (17)

1. Bang-Andersen B, Ruhland T, Jørgensen M, et al. Discovery of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. J Med Chem 2011;54, 3206-221.
2. Mørk A, Montezinho LC, Hovelsø N, et al. Lu AA21004, a novel antidepressant, modulates neurotransmitter levels and theta oscillations, and exerts pro-cognitive effects in rats. Eur Neuropsychopharmacol 2011;21 (Suppl 3):S407-8.
3. Nutt DJ. Beyond psychoanaleptics-can we improve antidepressant drug nomenclature? J Psychopharmacol 2009;23:343-5
4. Baldwin DS, Loft H, Dragheim M. A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD). Eur Neuropsychopharmacol 2012;22:482-91.
5. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, 4th Edn, Text Revision (DSM-IV-TR). Washington DC: American Psychiatric Association, 2000
6. Montgomery S, A° sberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9. (Pubitemid 9136500)
7. ICH Harmonised Tripartite Guideline E6: Guideline for Good Clinical Practice 1996. Available at: http://www.fda.gov/downloads/drugs/ guidancecomplianceregulatoryinformation/guidances/ucm073122.pdf [Last accessed 9 July 2012]
8. World Medical Association (WMA), 2008. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. Available at: http://www.wma.net/en/30publications/10policies/b3/[Last accessed 9 July 2012]
9. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
10. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-5.
11. Guy W. Clinical Global Impressions (028-CGI). In: Guy W ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health, 1976:216-22
12. Sheehan KH, Sheehan DV. Assessing treatment effects in clinical trials with the Discan metric of the Sheehan Disability Scale. Int Clin Psychopharmacol 2008;23:70-83. (Pubitemid 351317279)
13. Wade A, Despiegel N, Reines EH. Escitalopram in the long-term treatment of major depressive disorder. Ann Clin Psychiatry 2006;18:83-9. (Pubitemid 43879895)
14. Dunner DL, Wilson M, Fava M, et al. Long-term tolerability and effectiveness of duloxetine in the treatment of major depressive disorder. Depress Anxiety 2008;25(5):E1-8.
15. Boulenger JP, Loft H, Florea I. A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder. J Psychopharmacol 2012, published online April 9 2012, doi:10.1177/ 0269881112441866
16. Thase ME. Effectiveness of antidepressants: comparative remission rates. J Clin Psychiatry 2003;64(Suppl 2):3-7. (Pubitemid 36231841)
17. Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry 2010;71:1259-72.